Do These Words From Moderna's President Mean Trouble for Vaccine Makers?

Do These Words From Moderna's President Mean Trouble for Vaccine Makers?
·4 min read

One of the biggest topics these days among coronavirus investors is vaccine efficacy. In fact, the president of vaccine maker Moderna (NASDAQ: MRNA) recently made a comment about how the variant is changing the vaccine landscape. Do these words from Moderna president Stephen Hoge signal difficult times ahead for vaccine makers?

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting